nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Ibuprofen—Procarbazine—hematologic cancer	0.277	0.414	CrCrCtD
Sotalol—Atenolol—Procarbazine—hematologic cancer	0.247	0.369	CrCrCtD
Sotalol—Ibuprofen—Melphalan—hematologic cancer	0.146	0.217	CrCrCtD
Sotalol—Isoprenaline—PIK3R1—hematologic cancer	0.00191	0.563	CrCbGaD
Sotalol—Ibuprofen—BCL2—hematologic cancer	0.000484	0.143	CrCbGaD
Sotalol—Ibuprofen—UGT1A1—hematologic cancer	0.000412	0.122	CrCbGaD
Sotalol—Atenolol—ABCB1—hematologic cancer	0.000216	0.0638	CrCbGaD
Sotalol—Metoprolol—ABCB1—hematologic cancer	0.000168	0.0497	CrCbGaD
Sotalol—Ibuprofen—ALB—hematologic cancer	0.000101	0.0298	CrCbGaD
Sotalol—Ibuprofen—ABCB1—hematologic cancer	9.63e-05	0.0285	CrCbGaD
Sotalol—Asthenia—Cisplatin—hematologic cancer	4.19e-05	0.000155	CcSEcCtD
Sotalol—Fatigue—Triamcinolone—hematologic cancer	4.19e-05	0.000154	CcSEcCtD
Sotalol—Rash—Vincristine—hematologic cancer	4.17e-05	0.000154	CcSEcCtD
Sotalol—Dermatitis—Vincristine—hematologic cancer	4.16e-05	0.000154	CcSEcCtD
Sotalol—Pain—Triamcinolone—hematologic cancer	4.15e-05	0.000153	CcSEcCtD
Sotalol—Headache—Vincristine—hematologic cancer	4.14e-05	0.000153	CcSEcCtD
Sotalol—Loss of consciousness—Prednisone—hematologic cancer	4.13e-05	0.000152	CcSEcCtD
Sotalol—Hypotension—Betamethasone—hematologic cancer	4.12e-05	0.000152	CcSEcCtD
Sotalol—Hypotension—Dexamethasone—hematologic cancer	4.12e-05	0.000152	CcSEcCtD
Sotalol—Nausea—Carmustine—hematologic cancer	4.11e-05	0.000152	CcSEcCtD
Sotalol—Angiopathy—Methotrexate—hematologic cancer	4.09e-05	0.000151	CcSEcCtD
Sotalol—Vomiting—Mitoxantrone—hematologic cancer	4.09e-05	0.000151	CcSEcCtD
Sotalol—Vomiting—Irinotecan—hematologic cancer	4.09e-05	0.000151	CcSEcCtD
Sotalol—Nausea—Alitretinoin—hematologic cancer	4.07e-05	0.00015	CcSEcCtD
Sotalol—Visual impairment—Epirubicin—hematologic cancer	4.07e-05	0.00015	CcSEcCtD
Sotalol—Agranulocytosis—Doxorubicin—hematologic cancer	4.06e-05	0.00015	CcSEcCtD
Sotalol—Hypertension—Prednisone—hematologic cancer	4.06e-05	0.00015	CcSEcCtD
Sotalol—Rash—Mitoxantrone—hematologic cancer	4.06e-05	0.00015	CcSEcCtD
Sotalol—Rash—Irinotecan—hematologic cancer	4.06e-05	0.00015	CcSEcCtD
Sotalol—Dermatitis—Irinotecan—hematologic cancer	4.05e-05	0.00015	CcSEcCtD
Sotalol—Dermatitis—Mitoxantrone—hematologic cancer	4.05e-05	0.00015	CcSEcCtD
Sotalol—Headache—Mitoxantrone—hematologic cancer	4.03e-05	0.000149	CcSEcCtD
Sotalol—Headache—Irinotecan—hematologic cancer	4.03e-05	0.000149	CcSEcCtD
Sotalol—Nausea—Ifosfamide—hematologic cancer	4.02e-05	0.000149	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.01e-05	0.000148	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.01e-05	0.000148	CcSEcCtD
Sotalol—Myalgia—Prednisone—hematologic cancer	4e-05	0.000148	CcSEcCtD
Sotalol—Diarrhoea—Cisplatin—hematologic cancer	4e-05	0.000148	CcSEcCtD
Sotalol—Anxiety—Prednisone—hematologic cancer	3.99e-05	0.000147	CcSEcCtD
Sotalol—Alopecia—Methotrexate—hematologic cancer	3.99e-05	0.000147	CcSEcCtD
Sotalol—Vomiting—Gemcitabine—hematologic cancer	3.98e-05	0.000147	CcSEcCtD
Sotalol—Insomnia—Betamethasone—hematologic cancer	3.98e-05	0.000147	CcSEcCtD
Sotalol—Insomnia—Dexamethasone—hematologic cancer	3.98e-05	0.000147	CcSEcCtD
Sotalol—Bradycardia—Doxorubicin—hematologic cancer	3.98e-05	0.000147	CcSEcCtD
Sotalol—Paraesthesia—Betamethasone—hematologic cancer	3.95e-05	0.000146	CcSEcCtD
Sotalol—Paraesthesia—Dexamethasone—hematologic cancer	3.95e-05	0.000146	CcSEcCtD
Sotalol—Rash—Gemcitabine—hematologic cancer	3.95e-05	0.000146	CcSEcCtD
Sotalol—Dermatitis—Gemcitabine—hematologic cancer	3.95e-05	0.000146	CcSEcCtD
Sotalol—Haemoglobin—Doxorubicin—hematologic cancer	3.93e-05	0.000145	CcSEcCtD
Sotalol—Headache—Gemcitabine—hematologic cancer	3.93e-05	0.000145	CcSEcCtD
Sotalol—Nausea—Vincristine—hematologic cancer	3.92e-05	0.000145	CcSEcCtD
Sotalol—Haemorrhage—Doxorubicin—hematologic cancer	3.91e-05	0.000144	CcSEcCtD
Sotalol—Dyspepsia—Dexamethasone—hematologic cancer	3.88e-05	0.000143	CcSEcCtD
Sotalol—Dyspepsia—Betamethasone—hematologic cancer	3.88e-05	0.000143	CcSEcCtD
Sotalol—Dysgeusia—Methotrexate—hematologic cancer	3.85e-05	0.000142	CcSEcCtD
Sotalol—Asthenia—Etoposide—hematologic cancer	3.84e-05	0.000142	CcSEcCtD
Sotalol—Body temperature increased—Triamcinolone—hematologic cancer	3.84e-05	0.000142	CcSEcCtD
Sotalol—Oedema—Prednisone—hematologic cancer	3.84e-05	0.000142	CcSEcCtD
Sotalol—Angiopathy—Epirubicin—hematologic cancer	3.83e-05	0.000141	CcSEcCtD
Sotalol—Decreased appetite—Dexamethasone—hematologic cancer	3.83e-05	0.000141	CcSEcCtD
Sotalol—Decreased appetite—Betamethasone—hematologic cancer	3.83e-05	0.000141	CcSEcCtD
Sotalol—Nausea—Irinotecan—hematologic cancer	3.82e-05	0.000141	CcSEcCtD
Sotalol—Nausea—Mitoxantrone—hematologic cancer	3.82e-05	0.000141	CcSEcCtD
Sotalol—Infection—Prednisone—hematologic cancer	3.81e-05	0.000141	CcSEcCtD
Sotalol—Back pain—Methotrexate—hematologic cancer	3.8e-05	0.00014	CcSEcCtD
Sotalol—Fatigue—Betamethasone—hematologic cancer	3.8e-05	0.00014	CcSEcCtD
Sotalol—Fatigue—Dexamethasone—hematologic cancer	3.8e-05	0.00014	CcSEcCtD
Sotalol—Pruritus—Etoposide—hematologic cancer	3.79e-05	0.00014	CcSEcCtD
Sotalol—Shock—Prednisone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Sotalol—Arrhythmia—Epirubicin—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Sotalol—Pain—Betamethasone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Sotalol—Pain—Dexamethasone—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Sotalol—Visual impairment—Doxorubicin—hematologic cancer	3.77e-05	0.000139	CcSEcCtD
Sotalol—Alopecia—Epirubicin—hematologic cancer	3.73e-05	0.000138	CcSEcCtD
Sotalol—Nausea—Gemcitabine—hematologic cancer	3.72e-05	0.000137	CcSEcCtD
Sotalol—Vomiting—Cisplatin—hematologic cancer	3.71e-05	0.000137	CcSEcCtD
Sotalol—Hyperhidrosis—Prednisone—hematologic cancer	3.71e-05	0.000137	CcSEcCtD
Sotalol—Vision blurred—Methotrexate—hematologic cancer	3.7e-05	0.000137	CcSEcCtD
Sotalol—Rash—Cisplatin—hematologic cancer	3.68e-05	0.000136	CcSEcCtD
Sotalol—Dermatitis—Cisplatin—hematologic cancer	3.68e-05	0.000136	CcSEcCtD
Sotalol—Diarrhoea—Etoposide—hematologic cancer	3.66e-05	0.000135	CcSEcCtD
Sotalol—Flatulence—Epirubicin—hematologic cancer	3.62e-05	0.000134	CcSEcCtD
Sotalol—Gastrointestinal pain—Betamethasone—hematologic cancer	3.6e-05	0.000133	CcSEcCtD
Sotalol—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.6e-05	0.000133	CcSEcCtD
Sotalol—Dysgeusia—Epirubicin—hematologic cancer	3.6e-05	0.000133	CcSEcCtD
Sotalol—Back pain—Epirubicin—hematologic cancer	3.56e-05	0.000131	CcSEcCtD
Sotalol—Angiopathy—Doxorubicin—hematologic cancer	3.54e-05	0.000131	CcSEcCtD
Sotalol—Dizziness—Etoposide—hematologic cancer	3.54e-05	0.000131	CcSEcCtD
Sotalol—Muscle spasms—Epirubicin—hematologic cancer	3.53e-05	0.00013	CcSEcCtD
Sotalol—Vertigo—Methotrexate—hematologic cancer	3.53e-05	0.00013	CcSEcCtD
Sotalol—Leukopenia—Methotrexate—hematologic cancer	3.52e-05	0.00013	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.49e-05	0.000129	CcSEcCtD
Sotalol—Dizziness—Prednisolone—hematologic cancer	3.49e-05	0.000129	CcSEcCtD
Sotalol—Arrhythmia—Doxorubicin—hematologic cancer	3.49e-05	0.000129	CcSEcCtD
Sotalol—Asthenia—Triamcinolone—hematologic cancer	3.48e-05	0.000129	CcSEcCtD
Sotalol—Abdominal pain—Dexamethasone—hematologic cancer	3.48e-05	0.000128	CcSEcCtD
Sotalol—Abdominal pain—Betamethasone—hematologic cancer	3.48e-05	0.000128	CcSEcCtD
Sotalol—Body temperature increased—Betamethasone—hematologic cancer	3.48e-05	0.000128	CcSEcCtD
Sotalol—Body temperature increased—Dexamethasone—hematologic cancer	3.48e-05	0.000128	CcSEcCtD
Sotalol—Nausea—Cisplatin—hematologic cancer	3.47e-05	0.000128	CcSEcCtD
Sotalol—Insomnia—Prednisone—hematologic cancer	3.47e-05	0.000128	CcSEcCtD
Sotalol—Vision blurred—Epirubicin—hematologic cancer	3.46e-05	0.000128	CcSEcCtD
Sotalol—Alopecia—Doxorubicin—hematologic cancer	3.45e-05	0.000127	CcSEcCtD
Sotalol—Paraesthesia—Prednisone—hematologic cancer	3.44e-05	0.000127	CcSEcCtD
Sotalol—Pruritus—Triamcinolone—hematologic cancer	3.43e-05	0.000127	CcSEcCtD
Sotalol—Cough—Methotrexate—hematologic cancer	3.43e-05	0.000126	CcSEcCtD
Sotalol—Vomiting—Etoposide—hematologic cancer	3.4e-05	0.000126	CcSEcCtD
Sotalol—Dyspepsia—Prednisone—hematologic cancer	3.38e-05	0.000125	CcSEcCtD
Sotalol—Rash—Etoposide—hematologic cancer	3.37e-05	0.000125	CcSEcCtD
Sotalol—Dermatitis—Etoposide—hematologic cancer	3.37e-05	0.000124	CcSEcCtD
Sotalol—Headache—Etoposide—hematologic cancer	3.35e-05	0.000124	CcSEcCtD
Sotalol—Flatulence—Doxorubicin—hematologic cancer	3.35e-05	0.000124	CcSEcCtD
Sotalol—Myalgia—Methotrexate—hematologic cancer	3.34e-05	0.000123	CcSEcCtD
Sotalol—Chest pain—Methotrexate—hematologic cancer	3.34e-05	0.000123	CcSEcCtD
Sotalol—Decreased appetite—Prednisone—hematologic cancer	3.33e-05	0.000123	CcSEcCtD
Sotalol—Dysgeusia—Doxorubicin—hematologic cancer	3.33e-05	0.000123	CcSEcCtD
Sotalol—Rash—Prednisolone—hematologic cancer	3.33e-05	0.000123	CcSEcCtD
Sotalol—Dermatitis—Prednisolone—hematologic cancer	3.33e-05	0.000123	CcSEcCtD
Sotalol—Fatigue—Prednisone—hematologic cancer	3.31e-05	0.000122	CcSEcCtD
Sotalol—Headache—Prednisolone—hematologic cancer	3.31e-05	0.000122	CcSEcCtD
Sotalol—Vertigo—Epirubicin—hematologic cancer	3.3e-05	0.000122	CcSEcCtD
Sotalol—Syncope—Epirubicin—hematologic cancer	3.3e-05	0.000122	CcSEcCtD
Sotalol—Leukopenia—Epirubicin—hematologic cancer	3.29e-05	0.000121	CcSEcCtD
Sotalol—Back pain—Doxorubicin—hematologic cancer	3.29e-05	0.000121	CcSEcCtD
Sotalol—Muscle spasms—Doxorubicin—hematologic cancer	3.27e-05	0.000121	CcSEcCtD
Sotalol—Palpitations—Epirubicin—hematologic cancer	3.25e-05	0.00012	CcSEcCtD
Sotalol—Loss of consciousness—Epirubicin—hematologic cancer	3.23e-05	0.000119	CcSEcCtD
Sotalol—Dizziness—Triamcinolone—hematologic cancer	3.21e-05	0.000118	CcSEcCtD
Sotalol—Cough—Epirubicin—hematologic cancer	3.21e-05	0.000118	CcSEcCtD
Sotalol—Vision blurred—Doxorubicin—hematologic cancer	3.21e-05	0.000118	CcSEcCtD
Sotalol—Infection—Methotrexate—hematologic cancer	3.18e-05	0.000118	CcSEcCtD
Sotalol—Nausea—Etoposide—hematologic cancer	3.18e-05	0.000117	CcSEcCtD
Sotalol—Hypertension—Epirubicin—hematologic cancer	3.17e-05	0.000117	CcSEcCtD
Sotalol—Asthenia—Betamethasone—hematologic cancer	3.16e-05	0.000117	CcSEcCtD
Sotalol—Asthenia—Dexamethasone—hematologic cancer	3.16e-05	0.000117	CcSEcCtD
Sotalol—Thrombocytopenia—Methotrexate—hematologic cancer	3.14e-05	0.000116	CcSEcCtD
Sotalol—Gastrointestinal pain—Prednisone—hematologic cancer	3.14e-05	0.000116	CcSEcCtD
Sotalol—Nausea—Prednisolone—hematologic cancer	3.14e-05	0.000116	CcSEcCtD
Sotalol—Myalgia—Epirubicin—hematologic cancer	3.13e-05	0.000115	CcSEcCtD
Sotalol—Chest pain—Epirubicin—hematologic cancer	3.13e-05	0.000115	CcSEcCtD
Sotalol—Anxiety—Epirubicin—hematologic cancer	3.12e-05	0.000115	CcSEcCtD
Sotalol—Pruritus—Dexamethasone—hematologic cancer	3.12e-05	0.000115	CcSEcCtD
Sotalol—Pruritus—Betamethasone—hematologic cancer	3.12e-05	0.000115	CcSEcCtD
Sotalol—Hyperhidrosis—Methotrexate—hematologic cancer	3.1e-05	0.000114	CcSEcCtD
Sotalol—Vomiting—Triamcinolone—hematologic cancer	3.09e-05	0.000114	CcSEcCtD
Sotalol—Rash—Triamcinolone—hematologic cancer	3.06e-05	0.000113	CcSEcCtD
Sotalol—Dermatitis—Triamcinolone—hematologic cancer	3.06e-05	0.000113	CcSEcCtD
Sotalol—Vertigo—Doxorubicin—hematologic cancer	3.06e-05	0.000113	CcSEcCtD
Sotalol—Syncope—Doxorubicin—hematologic cancer	3.05e-05	0.000113	CcSEcCtD
Sotalol—Leukopenia—Doxorubicin—hematologic cancer	3.04e-05	0.000112	CcSEcCtD
Sotalol—Headache—Triamcinolone—hematologic cancer	3.04e-05	0.000112	CcSEcCtD
Sotalol—Abdominal pain—Prednisone—hematologic cancer	3.03e-05	0.000112	CcSEcCtD
Sotalol—Body temperature increased—Prednisone—hematologic cancer	3.03e-05	0.000112	CcSEcCtD
Sotalol—Diarrhoea—Betamethasone—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Sotalol—Diarrhoea—Dexamethasone—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Sotalol—Palpitations—Doxorubicin—hematologic cancer	3.01e-05	0.000111	CcSEcCtD
Sotalol—Oedema—Epirubicin—hematologic cancer	3e-05	0.000111	CcSEcCtD
Sotalol—Hypotension—Methotrexate—hematologic cancer	3e-05	0.000111	CcSEcCtD
Sotalol—Loss of consciousness—Doxorubicin—hematologic cancer	2.99e-05	0.00011	CcSEcCtD
Sotalol—Infection—Epirubicin—hematologic cancer	2.98e-05	0.00011	CcSEcCtD
Sotalol—Cough—Doxorubicin—hematologic cancer	2.97e-05	0.00011	CcSEcCtD
Sotalol—Shock—Epirubicin—hematologic cancer	2.95e-05	0.000109	CcSEcCtD
Sotalol—Thrombocytopenia—Epirubicin—hematologic cancer	2.94e-05	0.000108	CcSEcCtD
Sotalol—Hypertension—Doxorubicin—hematologic cancer	2.94e-05	0.000108	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.92e-05	0.000108	CcSEcCtD
Sotalol—Dizziness—Dexamethasone—hematologic cancer	2.91e-05	0.000107	CcSEcCtD
Sotalol—Dizziness—Betamethasone—hematologic cancer	2.91e-05	0.000107	CcSEcCtD
Sotalol—Hyperhidrosis—Epirubicin—hematologic cancer	2.9e-05	0.000107	CcSEcCtD
Sotalol—Insomnia—Methotrexate—hematologic cancer	2.9e-05	0.000107	CcSEcCtD
Sotalol—Myalgia—Doxorubicin—hematologic cancer	2.9e-05	0.000107	CcSEcCtD
Sotalol—Chest pain—Doxorubicin—hematologic cancer	2.9e-05	0.000107	CcSEcCtD
Sotalol—Anxiety—Doxorubicin—hematologic cancer	2.89e-05	0.000106	CcSEcCtD
Sotalol—Nausea—Triamcinolone—hematologic cancer	2.88e-05	0.000106	CcSEcCtD
Sotalol—Paraesthesia—Methotrexate—hematologic cancer	2.88e-05	0.000106	CcSEcCtD
Sotalol—Dyspnoea—Methotrexate—hematologic cancer	2.86e-05	0.000105	CcSEcCtD
Sotalol—Somnolence—Methotrexate—hematologic cancer	2.85e-05	0.000105	CcSEcCtD
Sotalol—Dyspepsia—Methotrexate—hematologic cancer	2.82e-05	0.000104	CcSEcCtD
Sotalol—Hypotension—Epirubicin—hematologic cancer	2.8e-05	0.000103	CcSEcCtD
Sotalol—Vomiting—Dexamethasone—hematologic cancer	2.8e-05	0.000103	CcSEcCtD
Sotalol—Vomiting—Betamethasone—hematologic cancer	2.8e-05	0.000103	CcSEcCtD
Sotalol—Decreased appetite—Methotrexate—hematologic cancer	2.79e-05	0.000103	CcSEcCtD
Sotalol—Rash—Betamethasone—hematologic cancer	2.78e-05	0.000102	CcSEcCtD
Sotalol—Rash—Dexamethasone—hematologic cancer	2.78e-05	0.000102	CcSEcCtD
Sotalol—Oedema—Doxorubicin—hematologic cancer	2.78e-05	0.000102	CcSEcCtD
Sotalol—Dermatitis—Betamethasone—hematologic cancer	2.77e-05	0.000102	CcSEcCtD
Sotalol—Dermatitis—Dexamethasone—hematologic cancer	2.77e-05	0.000102	CcSEcCtD
Sotalol—Fatigue—Methotrexate—hematologic cancer	2.76e-05	0.000102	CcSEcCtD
Sotalol—Headache—Betamethasone—hematologic cancer	2.76e-05	0.000102	CcSEcCtD
Sotalol—Headache—Dexamethasone—hematologic cancer	2.76e-05	0.000102	CcSEcCtD
Sotalol—Infection—Doxorubicin—hematologic cancer	2.76e-05	0.000102	CcSEcCtD
Sotalol—Asthenia—Prednisone—hematologic cancer	2.75e-05	0.000102	CcSEcCtD
Sotalol—Pain—Methotrexate—hematologic cancer	2.74e-05	0.000101	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.73e-05	0.000101	CcSEcCtD
Sotalol—Shock—Doxorubicin—hematologic cancer	2.73e-05	0.000101	CcSEcCtD
Sotalol—Thrombocytopenia—Doxorubicin—hematologic cancer	2.72e-05	0.0001	CcSEcCtD
Sotalol—Pruritus—Prednisone—hematologic cancer	2.71e-05	0.0001	CcSEcCtD
Sotalol—Insomnia—Epirubicin—hematologic cancer	2.71e-05	0.0001	CcSEcCtD
Sotalol—Paraesthesia—Epirubicin—hematologic cancer	2.69e-05	9.94e-05	CcSEcCtD
Sotalol—Hyperhidrosis—Doxorubicin—hematologic cancer	2.68e-05	9.9e-05	CcSEcCtD
Sotalol—Dyspnoea—Epirubicin—hematologic cancer	2.67e-05	9.87e-05	CcSEcCtD
Sotalol—Somnolence—Epirubicin—hematologic cancer	2.67e-05	9.84e-05	CcSEcCtD
Sotalol—Dyspepsia—Epirubicin—hematologic cancer	2.64e-05	9.75e-05	CcSEcCtD
Sotalol—Diarrhoea—Prednisone—hematologic cancer	2.62e-05	9.68e-05	CcSEcCtD
Sotalol—Gastrointestinal pain—Methotrexate—hematologic cancer	2.62e-05	9.67e-05	CcSEcCtD
Sotalol—Nausea—Betamethasone—hematologic cancer	2.62e-05	9.65e-05	CcSEcCtD
Sotalol—Nausea—Dexamethasone—hematologic cancer	2.62e-05	9.65e-05	CcSEcCtD
Sotalol—Decreased appetite—Epirubicin—hematologic cancer	2.61e-05	9.62e-05	CcSEcCtD
Sotalol—Hypotension—Doxorubicin—hematologic cancer	2.59e-05	9.57e-05	CcSEcCtD
Sotalol—Fatigue—Epirubicin—hematologic cancer	2.59e-05	9.54e-05	CcSEcCtD
Sotalol—Pain—Epirubicin—hematologic cancer	2.57e-05	9.47e-05	CcSEcCtD
Sotalol—Dizziness—Prednisone—hematologic cancer	2.54e-05	9.36e-05	CcSEcCtD
Sotalol—Abdominal pain—Methotrexate—hematologic cancer	2.53e-05	9.35e-05	CcSEcCtD
Sotalol—Body temperature increased—Methotrexate—hematologic cancer	2.53e-05	9.35e-05	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.53e-05	9.33e-05	CcSEcCtD
Sotalol—Insomnia—Doxorubicin—hematologic cancer	2.51e-05	9.26e-05	CcSEcCtD
Sotalol—Paraesthesia—Doxorubicin—hematologic cancer	2.49e-05	9.2e-05	CcSEcCtD
Sotalol—Dyspnoea—Doxorubicin—hematologic cancer	2.47e-05	9.13e-05	CcSEcCtD
Sotalol—Somnolence—Doxorubicin—hematologic cancer	2.47e-05	9.11e-05	CcSEcCtD
Sotalol—Gastrointestinal pain—Epirubicin—hematologic cancer	2.45e-05	9.05e-05	CcSEcCtD
Sotalol—Dyspepsia—Doxorubicin—hematologic cancer	2.44e-05	9.02e-05	CcSEcCtD
Sotalol—Vomiting—Prednisone—hematologic cancer	2.44e-05	9e-05	CcSEcCtD
Sotalol—Rash—Prednisone—hematologic cancer	2.42e-05	8.92e-05	CcSEcCtD
Sotalol—Dermatitis—Prednisone—hematologic cancer	2.42e-05	8.92e-05	CcSEcCtD
Sotalol—Decreased appetite—Doxorubicin—hematologic cancer	2.41e-05	8.9e-05	CcSEcCtD
Sotalol—Headache—Prednisone—hematologic cancer	2.4e-05	8.87e-05	CcSEcCtD
Sotalol—Fatigue—Doxorubicin—hematologic cancer	2.39e-05	8.83e-05	CcSEcCtD
Sotalol—Pain—Doxorubicin—hematologic cancer	2.37e-05	8.76e-05	CcSEcCtD
Sotalol—Body temperature increased—Epirubicin—hematologic cancer	2.37e-05	8.75e-05	CcSEcCtD
Sotalol—Abdominal pain—Epirubicin—hematologic cancer	2.37e-05	8.75e-05	CcSEcCtD
Sotalol—Asthenia—Methotrexate—hematologic cancer	2.3e-05	8.49e-05	CcSEcCtD
Sotalol—Nausea—Prednisone—hematologic cancer	2.28e-05	8.41e-05	CcSEcCtD
Sotalol—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.27e-05	8.38e-05	CcSEcCtD
Sotalol—Pruritus—Methotrexate—hematologic cancer	2.27e-05	8.37e-05	CcSEcCtD
Sotalol—Abdominal pain—Doxorubicin—hematologic cancer	2.19e-05	8.1e-05	CcSEcCtD
Sotalol—Body temperature increased—Doxorubicin—hematologic cancer	2.19e-05	8.1e-05	CcSEcCtD
Sotalol—Diarrhoea—Methotrexate—hematologic cancer	2.19e-05	8.09e-05	CcSEcCtD
Sotalol—Asthenia—Epirubicin—hematologic cancer	2.15e-05	7.94e-05	CcSEcCtD
Sotalol—Pruritus—Epirubicin—hematologic cancer	2.12e-05	7.83e-05	CcSEcCtD
Sotalol—Dizziness—Methotrexate—hematologic cancer	2.12e-05	7.82e-05	CcSEcCtD
Sotalol—Diarrhoea—Epirubicin—hematologic cancer	2.05e-05	7.57e-05	CcSEcCtD
Sotalol—Vomiting—Methotrexate—hematologic cancer	2.04e-05	7.52e-05	CcSEcCtD
Sotalol—Rash—Methotrexate—hematologic cancer	2.02e-05	7.46e-05	CcSEcCtD
Sotalol—Dermatitis—Methotrexate—hematologic cancer	2.02e-05	7.45e-05	CcSEcCtD
Sotalol—Headache—Methotrexate—hematologic cancer	2.01e-05	7.41e-05	CcSEcCtD
Sotalol—Asthenia—Doxorubicin—hematologic cancer	1.99e-05	7.35e-05	CcSEcCtD
Sotalol—Dizziness—Epirubicin—hematologic cancer	1.98e-05	7.32e-05	CcSEcCtD
Sotalol—Pruritus—Doxorubicin—hematologic cancer	1.96e-05	7.25e-05	CcSEcCtD
Sotalol—Vomiting—Epirubicin—hematologic cancer	1.91e-05	7.04e-05	CcSEcCtD
Sotalol—Nausea—Methotrexate—hematologic cancer	1.9e-05	7.03e-05	CcSEcCtD
Sotalol—Diarrhoea—Doxorubicin—hematologic cancer	1.9e-05	7.01e-05	CcSEcCtD
Sotalol—Rash—Epirubicin—hematologic cancer	1.89e-05	6.98e-05	CcSEcCtD
Sotalol—Dermatitis—Epirubicin—hematologic cancer	1.89e-05	6.97e-05	CcSEcCtD
Sotalol—Headache—Epirubicin—hematologic cancer	1.88e-05	6.94e-05	CcSEcCtD
Sotalol—Dizziness—Doxorubicin—hematologic cancer	1.84e-05	6.77e-05	CcSEcCtD
Sotalol—ADRB1—Signaling Pathways—STAT5B—hematologic cancer	1.82e-05	0.000327	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—JAK1—hematologic cancer	1.81e-05	0.000325	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PRKCG—hematologic cancer	1.81e-05	0.000325	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RAC2—hematologic cancer	1.81e-05	0.000324	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—DKK1—hematologic cancer	1.79e-05	0.000322	CbGpPWpGaD
Sotalol—Nausea—Epirubicin—hematologic cancer	1.78e-05	6.58e-05	CcSEcCtD
Sotalol—ADRB2—Signaling Pathways—STAT5B—hematologic cancer	1.78e-05	0.000319	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADCY7—hematologic cancer	1.77e-05	0.000317	CbGpPWpGaD
Sotalol—Vomiting—Doxorubicin—hematologic cancer	1.76e-05	6.51e-05	CcSEcCtD
Sotalol—Rash—Doxorubicin—hematologic cancer	1.75e-05	6.46e-05	CcSEcCtD
Sotalol—Dermatitis—Doxorubicin—hematologic cancer	1.75e-05	6.45e-05	CcSEcCtD
Sotalol—ADRB1—Signaling by GPCR—CSF2—hematologic cancer	1.74e-05	0.000313	CbGpPWpGaD
Sotalol—Headache—Doxorubicin—hematologic cancer	1.74e-05	6.42e-05	CcSEcCtD
Sotalol—ADRB1—GPCR downstream signaling—IL2RA—hematologic cancer	1.73e-05	0.00031	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADCY7—hematologic cancer	1.73e-05	0.00031	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—XIAP—hematologic cancer	1.72e-05	0.000308	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CSF2—hematologic cancer	1.7e-05	0.000306	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IL2RA—hematologic cancer	1.69e-05	0.000304	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—JAK1—hematologic cancer	1.68e-05	0.000302	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKCG—hematologic cancer	1.68e-05	0.000302	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—XIAP—hematologic cancer	1.68e-05	0.000302	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SH2B3—hematologic cancer	1.67e-05	0.000301	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SMARCA4—hematologic cancer	1.67e-05	0.000301	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GZMB—hematologic cancer	1.66e-05	0.000299	CbGpPWpGaD
Sotalol—Nausea—Doxorubicin—hematologic cancer	1.65e-05	6.08e-05	CcSEcCtD
Sotalol—ADRB2—Signaling by GPCR—PRKCG—hematologic cancer	1.64e-05	0.000295	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—JAK1—hematologic cancer	1.64e-05	0.000295	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SH2B3—hematologic cancer	1.64e-05	0.000294	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SMARCA4—hematologic cancer	1.64e-05	0.000294	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GZMB—hematologic cancer	1.63e-05	0.000292	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CTNNA1—hematologic cancer	1.62e-05	0.000292	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL3—hematologic cancer	1.61e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HSPB1—hematologic cancer	1.61e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EIF4EBP1—hematologic cancer	1.61e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTHLH—hematologic cancer	1.6e-05	0.000287	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SDC1—hematologic cancer	1.6e-05	0.000287	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CTNNA1—hematologic cancer	1.59e-05	0.000285	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EIF4EBP1—hematologic cancer	1.58e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL3—hematologic cancer	1.58e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HSPB1—hematologic cancer	1.58e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL2RA—hematologic cancer	1.57e-05	0.000282	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTHLH—hematologic cancer	1.56e-05	0.00028	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SDC1—hematologic cancer	1.56e-05	0.00028	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTGER4—hematologic cancer	1.55e-05	0.000279	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LCK—hematologic cancer	1.55e-05	0.000278	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL2RA—hematologic cancer	1.54e-05	0.000276	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTGER4—hematologic cancer	1.52e-05	0.000273	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—H3F3A—hematologic cancer	1.52e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LCK—hematologic cancer	1.51e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—H3F3A—hematologic cancer	1.48e-05	0.000266	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCZ—hematologic cancer	1.47e-05	0.000265	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCZ—hematologic cancer	1.44e-05	0.000259	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CG—hematologic cancer	1.44e-05	0.000259	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PARP1—hematologic cancer	1.42e-05	0.000256	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	1.41e-05	0.000253	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FBXW7—hematologic cancer	1.4e-05	0.000251	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PARP1—hematologic cancer	1.39e-05	0.00025	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HDAC2—hematologic cancer	1.37e-05	0.000247	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCR4—hematologic cancer	1.37e-05	0.000247	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	1.37e-05	0.000246	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	1.34e-05	0.000241	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	1.34e-05	0.000241	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CBL—hematologic cancer	1.34e-05	0.00024	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL3—hematologic cancer	1.32e-05	0.000238	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CBL—hematologic cancer	1.31e-05	0.000235	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CG—hematologic cancer	1.31e-05	0.000235	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTPN1—hematologic cancer	1.3e-05	0.000234	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL3—hematologic cancer	1.3e-05	0.000233	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PTPN11—hematologic cancer	1.29e-05	0.000231	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RASGRP1—hematologic cancer	1.28e-05	0.00023	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	1.28e-05	0.00023	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SYK—hematologic cancer	1.28e-05	0.000229	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HSP90AA1—hematologic cancer	1.28e-05	0.000229	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	1.27e-05	0.000229	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CD—hematologic cancer	1.27e-05	0.000227	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	1.26e-05	0.000226	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	1.25e-05	0.000225	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SYK—hematologic cancer	1.25e-05	0.000224	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	1.25e-05	0.000224	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CREB1—hematologic cancer	1.25e-05	0.000224	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	1.24e-05	0.000222	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT1—hematologic cancer	1.23e-05	0.000221	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL2—hematologic cancer	1.22e-05	0.000219	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	1.22e-05	0.000219	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6R—hematologic cancer	1.21e-05	0.000218	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT1—hematologic cancer	1.2e-05	0.000216	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	1.2e-05	0.000215	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	1.19e-05	0.000214	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	1.19e-05	0.000213	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	1.17e-05	0.00021	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	1.16e-05	0.000209	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	1.16e-05	0.000208	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	1.15e-05	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	1.15e-05	0.000206	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	1.15e-05	0.000206	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	1.14e-05	0.000204	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	1.13e-05	0.000203	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	1.13e-05	0.000203	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	1.13e-05	0.000202	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	1.12e-05	0.000202	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	1.12e-05	0.000202	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	1.11e-05	0.000199	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	1.11e-05	0.000199	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	1.1e-05	0.000198	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	1.1e-05	0.000197	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	1.09e-05	0.000195	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	1.08e-05	0.000194	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	1.08e-05	0.000194	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	1.07e-05	0.000193	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	1.06e-05	0.000191	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CD86—hematologic cancer	1.06e-05	0.000191	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	1.06e-05	0.000189	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HES1—hematologic cancer	1.05e-05	0.000188	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	1.04e-05	0.000187	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CD86—hematologic cancer	1.04e-05	0.000186	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	1.03e-05	0.000185	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	1.03e-05	0.000185	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	1.03e-05	0.000185	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HES1—hematologic cancer	1.02e-05	0.000184	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	1.02e-05	0.000183	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	1.01e-05	0.000182	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	1.01e-05	0.000182	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	1.01e-05	0.000182	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	1.01e-05	0.000181	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	1.01e-05	0.000181	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	1e-05	0.00018	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	9.97e-06	0.000179	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	9.93e-06	0.000178	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	9.93e-06	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	9.92e-06	0.000178	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	9.92e-06	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	9.9e-06	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	9.81e-06	0.000176	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	9.75e-06	0.000175	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	9.72e-06	0.000174	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	9.72e-06	0.000174	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	9.28e-06	0.000167	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	9.21e-06	0.000165	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TERT—hematologic cancer	9.17e-06	0.000165	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	9.07e-06	0.000163	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	9e-06	0.000162	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TERT—hematologic cancer	8.97e-06	0.000161	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	8.95e-06	0.000161	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	8.76e-06	0.000157	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	8.75e-06	0.000157	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	8.56e-06	0.000154	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	8.42e-06	0.000151	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	8.33e-06	0.00015	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	8.23e-06	0.000148	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	8.17e-06	0.000147	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	8.15e-06	0.000146	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FN1—hematologic cancer	8.07e-06	0.000145	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	8e-06	0.000144	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BAD—hematologic cancer	7.98e-06	0.000143	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	7.98e-06	0.000143	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	7.9e-06	0.000142	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FN1—hematologic cancer	7.9e-06	0.000142	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BAD—hematologic cancer	7.81e-06	0.00014	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	7.81e-06	0.00014	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CD80—hematologic cancer	7.74e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	7.73e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	7.73e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KIT—hematologic cancer	7.73e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	7.73e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	7.59e-06	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CD80—hematologic cancer	7.57e-06	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	7.56e-06	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KIT—hematologic cancer	7.56e-06	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	7.56e-06	0.000136	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	7.43e-06	0.000133	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	7.4e-06	0.000133	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	7.36e-06	0.000132	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	7.26e-06	0.00013	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	7.24e-06	0.00013	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	7.2e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	7.2e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	7.18e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	7.16e-06	0.000129	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	7.11e-06	0.000128	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	7.04e-06	0.000126	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	7.02e-06	0.000126	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	7.01e-06	0.000126	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	6.84e-06	0.000123	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	6.79e-06	0.000122	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.73e-06	0.000121	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	6.69e-06	0.00012	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	6.65e-06	0.000119	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	6.65e-06	0.000119	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	6.58e-06	0.000118	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	6.51e-06	0.000117	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	6.5e-06	0.000117	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	6.41e-06	0.000115	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	6.36e-06	0.000114	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	6.28e-06	0.000113	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	6.23e-06	0.000112	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	6.11e-06	0.00011	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	6.1e-06	0.000109	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	6.09e-06	0.000109	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	5.98e-06	0.000107	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	5.95e-06	0.000107	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	5.92e-06	0.000106	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	5.92e-06	0.000106	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	5.79e-06	0.000104	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	5.79e-06	0.000104	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	5.65e-06	0.000101	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	5.56e-06	9.98e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	5.53e-06	9.93e-05	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	5.5e-06	9.87e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	5.45e-06	9.78e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL2—hematologic cancer	5.44e-06	9.76e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	5.44e-06	9.76e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	5.41e-06	9.71e-05	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	5.38e-06	9.65e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	5.33e-06	9.56e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL2—hematologic cancer	5.32e-06	9.55e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	5.3e-06	9.52e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	5.29e-06	9.5e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JUN—hematologic cancer	5.29e-06	9.5e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	5.19e-06	9.31e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JUN—hematologic cancer	5.17e-06	9.29e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	5.13e-06	9.21e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	5.12e-06	9.19e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	5.02e-06	9.01e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	5.01e-06	8.99e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	5.01e-06	8.99e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	4.99e-06	8.96e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	4.9e-06	8.79e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	4.88e-06	8.77e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EP300—hematologic cancer	4.88e-06	8.76e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EP300—hematologic cancer	4.77e-06	8.57e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SRC—hematologic cancer	4.75e-06	8.52e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SRC—hematologic cancer	4.64e-06	8.33e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	4.62e-06	8.3e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	4.58e-06	8.21e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	4.56e-06	8.19e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	4.52e-06	8.12e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	4.48e-06	8.04e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	4.47e-06	8.02e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	4.37e-06	7.85e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	4.28e-06	7.68e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MYC—hematologic cancer	4.25e-06	7.63e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	4.24e-06	7.61e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MYC—hematologic cancer	4.16e-06	7.47e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	4.15e-06	7.45e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	3.93e-06	7.05e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	3.84e-06	6.9e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	3.61e-06	6.48e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	3.53e-06	6.34e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TP53—hematologic cancer	3.49e-06	6.27e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TP53—hematologic cancer	3.42e-06	6.13e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	3.34e-06	6e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	3.27e-06	5.86e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—hematologic cancer	3.2e-06	5.74e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—hematologic cancer	3.13e-06	5.61e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	2.95e-06	5.29e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	2.88e-06	5.18e-05	CbGpPWpGaD
